ArticleAdvances in therapy2024

A Phase I, Open-Label, Sequential, Single-Dose Clinical Trial to Evaluate the Pharmacokinetic, Pharmacodynamic, and Safety of IVL3001, a Finasteride-Based Novel Long-Acting Injection for Androgenetic Alopecia.

Heesun Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.